Developing A Baseline Metabolomic Signature Associated with COVID-19 Severity: Insights from Prospective Trials Encompassing 13 U.S. Centers

Metabolic disease is a significant risk factor for severe COVID-19 infection, but the contributing pathways are not yet fully elucidated. Using data from two randomized controlled trials across 13 U.S. academic centers, our goal was to characterize metabolic features that predict severe COVID-19 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kaifeng, Kang, Zhiyu, Guan, Weihua, Lotfi-Emran, Sahar, Mayer, Zachary J., Guerrero, Candace R., Steffen, Brian T., Puskarich, Michael A., Tignanelli, Christopher J., Lusczek, Elizabeth, Safo, Sandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672920/
https://www.ncbi.nlm.nih.gov/pubmed/37999202
http://dx.doi.org/10.3390/metabo13111107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672920/
https://www.ncbi.nlm.nih.gov/pubmed/37999202
http://dx.doi.org/10.3390/metabo13111107

Ejemplares similares